Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Your digital twin could help prevent another stroke

NCT ID NCT06714097

First seen May 01, 2026 · Last updated Jun 20, 2026 · Updated 9 times

Summary

This small study tests a smartphone app that creates a 'digital twin' of the patient to help manage health after a stroke, moyamoya disease, or cerebral amyloid angiopathy. Twenty adults will either use the app plus standard care, or standard care alone. The goal is to see if patients find the app helpful and easy to use, not to measure medical outcomes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STROKE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fondazione IRCCS Istituto Neurologico Carlo Besta

    RECRUITING

    Milan, Michigan, 20133, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

STRATIF-AI digital twin app (software)

What this could lead to

If it works, this could point toward a better way to help patients manage their health after a stroke or similar condition.

What could go wrong

This is a very small, early study with only 20 people. It is testing if the app is usable, not if it prevents strokes. The app may not improve health outcomes.

Conditions

The condition(s) this trial relates to.

cerebral amyloid angiopathy Moyamoya disease stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.